Novartis to resume production of two radioligand therapies after resolving manufacturing foul by Editor | Jul 1, 2022 | Hospitals, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0 SWITZERLAND – Novartis has resumed the production and delivery of radioligand therapy medicines... Read More